Pingfu Fu Selected Research

Breast Neoplasms (Breast Cancer)

5/2023	Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer.
1/2023	Survival in elderly patients with breast cancer with and without autoimmune disease.
10/2022	Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers.
1/2022	Real-World Practice of Hypofractionated Radiotherapy in Patients With Invasive Breast Cancer.
1/2022	Chemotherapy is a risk factor of lymphopenia before adjuvant radiotherapy in breast cancer.
8/2021	Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapy.
10/2013	MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer.
5/2009	A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkers.
10/2007	Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pingfu Fu Research Topics

Disease

73	Neoplasms (Cancer) 01/2024 - 01/2003
26	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2003
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2023 - 12/2005
11	Adenocarcinoma 07/2021 - 01/2003
9	Breast Neoplasms (Breast Cancer) 05/2023 - 10/2007
8	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023 - 06/2007
8	Lung Neoplasms (Lung Cancer) 11/2023 - 07/2008
8	Carcinogenesis 10/2017 - 05/2004
7	Neoplasm Metastasis (Metastasis) 01/2018 - 05/2004
6	Inflammation (Inflammations) 09/2021 - 09/2006
5	Multiple Myeloma 01/2024 - 08/2007
5	Squamous Cell Carcinoma of Head and Neck 11/2022 - 11/2015
5	Lymphoma (Lymphomas) 01/2020 - 01/2005
5	Disease Progression 04/2014 - 07/2004
4	Carcinoma (Carcinomatosis) 06/2023 - 01/2003
4	Infections 11/2022 - 02/2004
4	Colonic Neoplasms (Colon Cancer) 01/2022 - 07/2008
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2007
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2009 - 01/2005
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 05/2010
3	COVID-19 11/2022 - 11/2021
3	Adenocarcinoma of Lung 03/2019 - 07/2011
3	Pain (Aches) 06/2018 - 09/2009
3	Hematologic Neoplasms (Hematological Malignancy) 10/2017 - 04/2006
3	Mycosis Fungoides 01/2017 - 12/2010
3	Acquired Immunodeficiency Syndrome (AIDS) 06/2014 - 01/2005
3	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2011 - 02/2004
2	Hemorrhage 04/2024 - 09/2011
2	Melanoma (Melanoma, Malignant) 03/2024 - 12/2010
2	Abdominal Obesity 01/2024 - 09/2023
2	Triple Negative Breast Neoplasms 10/2023 - 10/2013
2	Body Weight (Weight, Body) 01/2023 - 10/2014
2	Exanthema (Rash) 11/2022 - 05/2013
2	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 01/2019
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 12/2020
2	Lymphopenia (Lymphocytopenia) 01/2022 - 08/2021
2	Prostatitis 09/2021 - 01/2003
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2017 - 05/2012

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 06/2023 - 05/2009
17	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2003
8	ApigeninIBA 10/2015 - 12/2005
7	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 07/2004
6	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2020
6	Docetaxel (Taxotere)FDA Link 01/2016 - 05/2009
5	Pemetrexed (MTA)FDA Link 01/2022 - 10/2013
5	Prostate-Specific Antigen (Semenogelase)IBA 09/2021 - 09/2006
5	Carmustine (FIVB)FDA Link 01/2017 - 01/2005
4	Eosine Yellowish-(YS) (Eosin)IBA 11/2022 - 11/2020
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2005
4	PlatinumIBA 01/2022 - 08/2014
4	Rituximab (Mabthera)FDA Link 01/2020 - 01/2006
4	ParaffinIBA 12/2018 - 01/2003
4	ErbB Receptors (EGF Receptor)IBA 01/2017 - 11/2009
4	Phosphotransferases (Kinase)IBA 10/2015 - 07/2011
4	Capromab Pendetide FDA Link 09/2011 - 01/2003
3	Carboplatin (JM8)FDA LinkGeneric 10/2023 - 10/2007
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 11/2015
3	Hematoxylin (Haematoxylon)IBA 11/2022 - 07/2021
3	methoxyamineIBA 01/2021 - 11/2016
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2019 - 12/2012
3	Messenger RNA (mRNA)IBA 01/2019 - 01/2003
3	Adenosine Monophosphate (AMP)IBA 01/2018 - 04/2013
3	fludarabineIBA 10/2017 - 10/2007
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017 - 11/2015
3	O(6)-benzylguanineIBA 01/2017 - 08/2007
3	Sorafenib (BAY 43-9006)FDA Link 08/2014 - 05/2013
3	Etoposide (VP 16)FDA LinkGeneric 04/2014 - 01/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2012 - 07/2004
3	rebeccamycinIBA 04/2012 - 12/2005
2	trans-crotonin (CTN)IBA 01/2024 - 09/2023
2	CalciumIBA 01/2022 - 01/2020
2	durvalumabIBA 01/2022 - 01/2022
2	Complement System Proteins (Complement)IBA 01/2022 - 05/2021
2	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 11/2012
2	Peptides (Polypeptides)IBA 01/2021 - 04/2013
2	thiamine triphosphorate (TTP)IBA 01/2020 - 03/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 07/2009
2	EnzymesIBA 01/2019 - 07/2008
2	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 10/2007
2	Formaldehyde (Formol)FDA Link 12/2018 - 01/2018
2	Protein Kinases (Protein Kinase)IBA 01/2018 - 10/2014
2	Transcription Factors (Transcription Factor)IBA 09/2017 - 02/2014
2	Alkyl and Aryl TransferasesIBA 01/2017 - 05/2012
2	Tyrosine Kinase InhibitorsIBA 11/2015 - 10/2013

Therapy/Procedure

31	Therapeutics 04/2024 - 12/2005
29	Drug Therapy (Chemotherapy) 12/2023 - 01/2005
13	Radiotherapy 12/2023 - 01/2003
8	Immunotherapy 12/2023 - 10/2013
8	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 01/2018
7	Cell Transplantation 01/2024 - 01/2006
5	Brachytherapy 09/2013 - 01/2003
3	Transplantation 03/2024 - 02/2004
3	Artificial Respiration (Mechanical Ventilation) 11/2022 - 11/2021
3	Adjuvant Chemotherapy 07/2021 - 01/2020
2	Art Therapy 01/2023 - 06/2014
2	Mechanical Ventilators (Ventilator) 01/2022 - 11/2021
2	Adjuvant Radiotherapy 01/2022 - 08/2021
2	Music Therapy 06/2018 - 08/2017
2	Castration 01/2018 - 10/2014
2	Autologous Transplantation 10/2016 - 01/2005